Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization
✍ Scribed by M. Castrucci; S. Sironi; F. De Cobelli; M. Salvioni; A. Del Maschio
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 568 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0942-8925
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Purpose: To investigate the incremental value of dynamic gadolinium‐enhancement performed immediately after ferumoxides‐enhanced magnetic resonance (MR) imaging on the detection of hepatocellular carcinoma in patients with cirrhosis. ## Materials and Methods: We retrospectively re
## Abstract The purpose of this study was to evaluate the ability of the new liver‐specific magnetic resonance contrast agent gadolinium‐ethoxybenzyl‐diethylenetriamine penta‐acetic acid (Gd‐EOB‐DTPA) to detect hepatocellular carcinoma (HCC). Seventeen mice with 66 chemically induced HCCs underwent
## Abstract ## Purpose: To determine histological and MR imaging differences between areas with Gd‐EOB‐DTPA (gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) uptake and without in hepatocellular carcinomas (HCCs) as seen on Gd‐EOB‐DTPA‐enhanced hepatobiliary‐phase MR images. ## Materi
## Abstract ## Purpose To evaluate ferumoxide‐enhanced MR imaging findings of hepatocellular carcinomas (HCCs) in correlation with the histologic tumor grades and the tumor vascularity evaluated by CT hepatic arteriography (CTHA) and CT during arterial portography (CTAP) combined. ## Materials an